|
CBFB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28229999951657E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.21289999996688E-07 |
| Normal-vs-Stage2 |
7.353700E-04 |
| Normal-vs-Stage3 |
4.82180000371812E-08 |
| Normal-vs-Stage4 |
1.56119994709769E-09 |
| Stage1-vs-Stage2 |
5.411600E-01 |
| Stage1-vs-Stage3 |
1.215550E-01 |
| Stage1-vs-Stage4 |
6.112100E-02 |
| Stage2-vs-Stage3 |
7.780000E-01 |
| Stage2-vs-Stage4 |
7.506600E-01 |
| Stage3-vs-Stage4 |
9.704000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.96160004590263E-09 |
| Normal-vs-AfricanAmerican |
1.743520E-02 |
| Normal-vs-Asian |
7.190500E-04 |
| Caucasian-vs-AfricanAmerican |
9.557600E-04 |
| Caucasian-vs-Asian |
2.438400E-01 |
| AfricanAmerican-vs-Asian |
7.798000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.49779999514266E-08 |
| Normal-vs-Female |
6.42129999950392E-07 |
| Male-vs-Female |
5.227000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.221100E-04 |
| Normal-vs-Age(41-60Yrs) |
9.00219998545282E-09 |
| Normal-vs-Age(61-80Yrs) |
5.56539999641004E-08 |
| Normal-vs-Age(81-100Yrs) |
2.298400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.744800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.496000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.568200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.431000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.674400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.555800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.114140E-02 |
| Normal-vs-Grade 2 |
2.14619999550081E-08 |
| Normal-vs-Grade 3 |
2.24520000036144E-07 |
| Normal-vs-Grade 4 |
1.72440000056895E-08 |
| Grade 1-vs-Grade 2 |
5.318800E-01 |
| Grade 1-vs-Grade 3 |
9.085200E-01 |
| Grade 1-vs-Grade 4 |
4.348600E-01 |
| Grade 2-vs-Grade 3 |
1.327630E-01 |
| Grade 2-vs-Grade 4 |
6.153200E-01 |
| Grade 3-vs-Grade 4 |
5.642000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.51469999876142E-08 |
| Normal-vs-ccB subtype |
6.30769999565572E-08 |
| ccA subtype-vs-ccB subtype |
9.482600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30309999457623E-08 |
| Normal-vs-N1 |
4.440000E-04 |
| N0-vs-N1 |
5.816200E-01 |
|
|
